Sana Biotechnology SANA
NASDAQ SANA
$2.89 -0.02 (-0.86%)
At close: Oct 1, 2026 · 4:00 PM EDT

Sana Biotechnology (SANA) Capital Expenditures (2020 - 2026)

Updated

Sana Biotechnology's Capital Expenditures was $1.62 million in Q2 2026, compared with -$112,000 a year earlier and up 462.8% from the prior quarter.

Analysis

Sana Biotechnology (SANA) Capital Expenditures (2020 - 2026) Analysis & Trends

On a trailing twelve-month basis, Sana Biotechnology's Capital Expenditures was $2.82 million through Jun 30, 2026, down 38.0% year-over-year; for FY2025, it was $938,000, down 97.2% from FY2024.

  • Capital Expenditures shows a five-year compound annual growth rate of -47.7% (FY2020 to FY2025).
  • In earlier years, Capital Expenditures was $33.43 million in FY2024 (+66.9%), $20.03 million in FY2023 (-4.0%), $20.88 million in FY2022 (-30.1%) and $29.86 million in FY2021 (+25.1%).
  • The Q2 2026 figure marks the highest quarterly Capital Expenditures since Q3 2024.
  • Compared with a year earlier, Capital Expenditures was higher in three of the last six quarters, with an average year-over-year change of 0.0%.
  • The best year-over-year quarter for Capital Expenditures over five years was Q2 2024 (growth of 727.9%); the worst was Q1 2025 (a decline of 99.1%).
  • Per Business Quant data, SANA's Capital Expenditures in the three quarters before Q2 2026 was $288,000 (Q1 2026), $873,000 (Q4 2025) and $41,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.32 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 322.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 893.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -321.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -763.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 513.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 140.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 533.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 112.20 Mn
10 Sana Biotechnology 870.98 Mn 870.98 Mn - 1.62 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.62 Mn
Mar 31, 2026 288,000.00
Dec 31, 2025 873,000.00
Sep 30, 2025 41,000.00
Jun 30, 2025 -112,000.00
Mar 31, 2025 136,000.00
Dec 31, 2024 436,000.00
Sep 30, 2024 4.09 Mn
Jun 30, 2024 13.06 Mn
Mar 31, 2024 15.85 Mn
Dec 31, 2023 14.05 Mn
Sep 30, 2023 2.23 Mn
Jun 30, 2023 1.58 Mn
Mar 31, 2023 2.18 Mn
Dec 31, 2022 4.60 Mn
Sep 30, 2022 4.35 Mn
Jun 30, 2022 4.39 Mn
Mar 31, 2022 7.53 Mn
Dec 31, 2021 5.20 Mn
Sep 30, 2021 8.06 Mn
API Access

Sana Biotechnology Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=SANA&period=max&api_key=YOUR_API_KEY